Novel Genomic Strategies for Personalized Cancer Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 549
Special Issue Editors
Interests: precision medicine; molecular diagnostics; viro-therapeutics
Special Issue Information
Dear Colleagues,
The era of one-size-fits-all cancer therapy is giving way to a precision oncology paradigm, driven by deep genomic characterization of individual tumors. Personalized cancer treatment utilizes genomic strategies to decipher the unique molecular blueprint of a patient's malignancy, identifying targetable alterations, prognostic signatures, and mechanisms of resistance. This approach integrates tools such as next-generation sequencing, liquid biopsies, and bioinformatic analyses to guide clinical decision-making. By matching specific genetic drivers with corresponding targeted therapies, these strategies maximize efficacy while minimizing exposure to ineffective treatments. Furthermore, genomic profiling enables the discovery of novel biomarkers, informs combination therapy regimens, and helps monitor clonal evolution during treatment. Ultimately, the integration of genomic data into clinical workflows is revolutionizing oncology, offering a more tailored, dynamic, and effective framework for patient care.
Dr. Honey Reddi
Dr. Guo-Min Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- assay validation
- solid tumors
- molecular methodologies
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
